Empowering emergency clinicians to rapidly recognize and act early on acute infections with unparalleled precision
Inflammatix Receives FDA Clearance for First-in-Class TriVerity™ Test
Rule in and rule out infection and severity quickly
-
Bacterial infection
-
Viral infection
-
Severe illness within 7 days*
*Defined as the risk of progression to needing mechanical ventilation, vasopressors, and/or renal replacement therapy (RRT) within seven days.
US emergency departments routinely see patients suspected of acute infection and sepsis
IMMUNE RESPONSE
Expertise in interpreting the immune response
Inflammatix host response diagnostics are powered by ‘reading’ the immune system. Our immune system has developed targeted responses to different types of infections and other diseases over millions of years of evolution.
Leveraging our expertise in bioinformatics, including machine learning and artificial intelligence, and molecular biology, we are harnessing the ability to interpret the immune response to develop tests aimed to help physicians make confident and timely clinical decisions.
Most infections are locally contained and do not penetrate into the bloodstream. This makes pathogen-targeting tests insensitive for infections. Immune cells fight the infection locally and then circulate into the blood, where we can measure their ‘signatures’ using mRNA profiles.